Labiotech.eu

News and Trends 31 May 2022

ANGLE and U.S. urology group to undertake prostate cancer study

ANGLE plc has signed a master clinical study agreement with Solaris Health Holdings, LLC and joinder agreements with MidLantic Urology LLC, to collaborate and conduct clinical studies in prostate cancer and as a potential route to market in the U.S. Alongside Solaris affiliate MidLantic Urology, UK-headquartered ANGLE will initiate clinical studies aimed at detecting prostate […]

May 31, 2022 - 5 minutesmins - By Jim Cornall

web3 decentralized autonomous organization vitaDAO biotech

In Depth 30 May 2022

Decentralized autonomous organizations are changing how biotechs are run

Built on the emerging ecosystems of Web3 and blockchain, decentralized autonomous organizations (DAOs) allow communities to collectively fund and advance biotech research. The majority of biotech companies are highly centralized with much of the data siloed away in their proprietary databases. Companies have no incentives to openly share this data, which slows down progress in […]

May 30, 2022 - 8 minutesmins - By Sachin Rawat

News and Trends 27 May 2022

Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites

Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two new U.S. sites. The new facilities are located at Indiana’s LEAP Lebanon Innovation and Research District in Boone County. David A. Ricks, Lilly’s chair and CEO, said: “These new sites will add capacity in support of our growing pipeline of […]

May 27, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 27 May 2022

HotSpot looks to boost cancer therapy pipeline with Excelra partnership

U.S. biotech company HotSpot Therapeutics, Inc. is looking to increase its drug development and discovery efforts by partnering with Indian data and digital insights company Excelra. HotSpot discovers and develops small molecule allosteric therapies for the treatment of cancer and autoimmune diseases. What are allosteric therapies? In the journal ACS Medicinal Chemistry Letters, Ahmed F. […]

May 27, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 27 May 2022

Companies partner on early lung cancer detection blood test

U.S. company CorePath Laboratories is partnering with U.K. diagnostics firm Cizzle Biotechnology on an early-stage lung cancer test for the U.S. Lung cancer is the leading cause of cancer deaths in the U.S., making up almost 25% of all cancer deaths. Each year, more people die of lung cancer than of colon, breast, and prostate […]

May 27, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 27 May 2022

Blue Lake Biotechnology RSV vaccine gets FDA fast track

U.S. company Blue Lake Biotechnology, Inc. has received U.S. Food and Drug Administration (FDA) Fast Track designation for its respiratory syncytial virus (RSV) intranasal vaccine. The biopharma company, a subsidiary of CyanVac LLC, develops vaccines using a parainfluenza virus 5 (PIV5)-based vector. The FDA Fast Track designation applies to BLB-201, a vaccine for the prevention […]

May 27, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 27 May 2022

Animal-free milk company Imagindairy reaches $28M in funding

Israeli foodtech startup Imagindairy, Ltd., developer of animal-free dairy milk proteins, has secured an additional $15M in its extended seed-round to bring the total investment so far to $28M. The alt-protein company creates animal-free milk proteins from microorganisms through precision-fermentation technology, which allows the production of a wide range of dairy analogs, from raw milk […]

May 27, 2022 - 4 minutesmins - By Jim Cornall

cancer dna damage repair duke street bio parp

News and Trends 25 May 2022

Duke Street Bio enters stage with next-generation cancer therapies

The UK startup Duke Street Bio has exited stealth mode with funding to develop PARP enzyme inhibitors that treat cancer by blocking the repair of DNA in tumor cells. London-based Duke Street Bio said Tuesday that it has a portfolio of PARP1 and PARP7 enzyme inhibitors and has raised enough cash to fund its pipeline […]

May 25, 2022 - 3 minutesmins - By Susannah Rodgers

Inside Labiotech 25 May 2022

Labiotech goes global

The past few months have been very exciting for our team. Following our recent acquisition by Inova, we’ve been working hard on defining the future of Labiotech. From our humble beginnings in France to our expansion into the European market, we’ve always been keen to explore new horizons for the benefit of our readers. Once […]

May 25, 2022 - 3 minutesmins - By Joachim Eeckhout

News and Trends 24 May 2022

Vaccines mobilized to control monkeypox outbreak

An unusual outbreak of monkeypox is causing concern worldwide in the shadow of the destructive Covid-19 pandemic. Both old and emerging vaccine technology could aid the fight against the outbreak. In the wake of the world-changing Covid-19 pandemic, the World Health Organization (WHO) is voicing alarm over another unusual outbreak, this time of the viral […]

May 24, 2022 - 5 minutesmins - By Jonathan Smith

In Depth 23 May 2022

The coming of age of European synthetic biology

Within a few years, synthetic biology has evolved from being a new player in the molecular biology and biotech arena to being a front-row contender with multiple industrial advances and large amounts of investor money. There have been a number of definitions of synthetic biology, also known as synbio. Generally, it involves redesigning genetic systems […]

May 23, 2022 - 8 minutesmins - By Helen Albert

glucagon zealand pharma diabetes insulin immunotherapy

News and Trends 20 May 2022

Zealand Pharma’s drug for rare metabolic disease smashes phase III

After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide drug improved blood sugar control in infants with the rare disease congenital hyperinsulinemia in a phase III trial. In late 2020, the Danish firm Zealand Pharma A/S hit a big obstacle when its peptide drug dasiglucagon failed to treat the […]

May 20, 2022 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

ANGLE and U.S. urology group to undertake prostate cancer study

Decentralized autonomous organizations are changing how biotechs are run

Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites

HotSpot looks to boost cancer therapy pipeline with Excelra partnership

Companies partner on early lung cancer detection blood test

Blue Lake Biotechnology RSV vaccine gets FDA fast track

Animal-free milk company Imagindairy reaches $28M in funding

Duke Street Bio enters stage with next-generation cancer therapies

Labiotech goes global

Vaccines mobilized to control monkeypox outbreak

The coming of age of European synthetic biology

Zealand Pharma’s drug for rare metabolic disease smashes phase III

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!